China Pharma(us:CPHI)

    0.1790

    +2.87%

    Updated on 2024-12-23

    Open:0.1700
    Close:0.1790
    High:0.1899
    Low:0.1628
    Pre Close:0.1740
    Volume:689718.00
    Amount:124002.55
    Turnover:3.58%
    Shares:19.25M
    MarketCap:3.45M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-307599920.35%403
    2024-03-3181159120.78%125
    2023-12-3191223720.23%413
    2023-09-3063054851.06%032
    2023-06-3061556901.84%202
    2023-03-3172386132.82%023
    2022-12-317898260.12%122
    2022-09-3095848261.16%116
    dateorgNametotalratiochangeShareschangeRatio
    2024-06-30Xtx Topco Ltd287370.17%28737
    2024-06-30Baader Bank Aktiengesellschaft203090.12%20309
    2024-06-30Susquehanna International Group, Llp109160.06%10916
    2024-06-30First Community Trust Na300.00%30
    2024-06-30Citadel Advisors Llc0-94296
    2024-06-30Ubs Group Ag0-7335
    2024-06-30Two Sigma Securities, Llc0-14281
    2024-03-31Citadel Advisors Llc942960.64%61053183.66%
    2024-03-31Two Sigma Securities, Llc142810.10%14281
    2024-03-31Ubs Group Ag73350.05%4756.92%

    About

    China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm’s product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.
    Address:No.17, Jinpan Road,2nd Floor

    Market Movers